SEPOY.net
No Result
View All Result
Sunday, July 20, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

Nicholas by Nicholas
March 11, 2023
in Health
0
Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

New research in the March 2023 issue of JNCCN-; Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer. In a first-of-its-kind study, the researchers evaluated molecular genetic results for 113 Black South African men diagnosed with advanced prostate cancer to find evidence for increased and potentially unique genetic testing recommendations.

READ ALSO

Hypertensive disorders in pregnancy linked to lower breastfeeding rates

Ancient viral DNA found to regulate human gene expression

The researchers point out that, according to the GLOBOCON 2020 studies, the regions of the world most impacted by prostate cancer mortality include populations with significant African ancestry, such as the Caribbean and the regions of Sub-Saharan Africa, with mortality rates 3.4- and 2.5-fold greater, than reported for the United States, respectively. Within the United States, African American men are at 2.3- to 5-times increased risk for prostate cancer associated death than their non-African American counterparts.

Although men of African ancestry have the highest incidence rates for aggressive prostate cancer and associated death globally, due to lack of available data, no tailored testing criteria have been established for such populations at increased risk. This study opens the door to begin to establish new criteria, providing men of African ancestry with hope that germline testing can change current disparities in clinical outcomes.”

Kazzem Gheybi, MD, PhD, Lead Researcher, The University of Sydney in Australia

“The African diaspora is highly diverse, so I caution against regarding the most genetically diverse population in ‘singular’ terms,” added senior researcher Vanessa M. Hayes, PhD, also from The University of Sydney and the University of Pretoria in South Africa. “What is required is concerted effort for inclusion that takes a grassroots approach. We need to build criteria based on population-specific knowledge. We encourage cancer care and germline screening providers to establish a research and development arm tailored specifically for African inclusion. We need to move away from the one-size-fits-all model for prostate cancer care; African solutions should address African-relevant disparities in prostate cancer outcomes.”

The study included a close examination of 21,899 single-nucleotide variants, 4,626 small insertions and deletions, and 73 structural variants across 20 genes from the 113 patients. After initially excluding variants that were known not to be cancer-causing, they found 38 mutations across 52 patients. A total of 17 pathogenic (4) and potential oncogenic (13) variants were identified. The 5.6% rate of rare cancer-causing variants in this population was significantly lower than the established rate of 11.8% for non-African patients with confirmed metastatic prostate cancer, suggesting decreased sensitivity of current gene panels for risk assessment in this patient population.

“This study highlights the poor clinical utility (30%) of the currently most-utilized germline testing panels in men of African ancestry, largely due to minimal inclusion of these groups in the development of the panels,” commented Samuel L. Washington III, MD, MAS, Assistant Professor of Urology; Epidemiology & Biostatistics, University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, who was not involved in this research.

Dr. Washington, who is also a Member of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Prostate Cancer Early Detection, continued: “This study emphasizes two crucial domains: 1) it provides further evidence of the need for greater inclusivity in genetic panel development and 2) it recognizes that disparities in outcomes for men of African ancestry can’t be explained solely by the findings in 113 Black South African males. Although the NCCN Guidelines for Prostate Cancer Early Detection identify Black/African American identity as a risk factor, the panel notes the contributions of poor access to care, social determinants of health/social risk, and heritable genes to these observations. I look forward to further research in this area that examines how the limitations of our current tools can be improved to better reflect the populations we serve.”

Source:

National Comprehensive Cancer Network

Tags: CancerCancer TreatmentEducationGenesGeneticGenomicGermlineMedicineMortalityOncologyProstateProstate CancerResearch

Related Posts

Hypertensive disorders in pregnancy linked to lower breastfeeding rates
Health

Hypertensive disorders in pregnancy linked to lower breastfeeding rates

July 19, 2025
Ancient viral DNA found to regulate human gene expression
Health

Ancient viral DNA found to regulate human gene expression

July 19, 2025
Agricultural dust exposure may pose significant risks to gut health
Health

Agricultural dust exposure may pose significant risks to gut health

July 19, 2025
Heart-healthy habits can improve overall physical and psychological well-being
Health

Heart-healthy habits can improve overall physical and psychological well-being

July 19, 2025
New insights into diagnosis and treatment of tibial tubercle avulsion fractures in young athletes
Health

New insights into diagnosis and treatment of tibial tubercle avulsion fractures in young athletes

July 19, 2025
Study reveals complex patterns of burden and survival among people with digestive system cancers in China
Health

Study reveals complex patterns of burden and survival among people with digestive system cancers in China

July 18, 2025
Next Post
Redoubling efforts to highlight the importance of colorectal cancer screening

Redoubling efforts to highlight the importance of colorectal cancer screening

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • one hundred Totally free Revolves No-deposit Product sales inside 2025 Best Websites & Incentives
  • Salle ma jeu aquatica kasino Bedste vinder online casino Eagles Annonce 2025 Le salle ma jeu continue dans chiffre black
  • Such Lost Treasures In Lovely Lady bonus game the us Have been Indeed Receive

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net